Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone
about
Characterization of a functional thrombin receptor. Issues and opportunitiesInhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding siteOriginal Article: Changes in Platelet Function, von Willebrand Factor and Factor VIII in Patients Undergoing Aorto-bifemoral By-pass with Dacron Grafts.Phospholipid binding plasma proteins required for antiphospholipid antibody detection--an overview.A surprising role for uric acid: the inflammatory malaria response.Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates."Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structureCloned platelet thrombin receptor is necessary for thrombin-induced platelet activationThrombin receptor expression in normal and atherosclerotic human arteries.The cleaved peptide of the thrombin receptor is a strong platelet agonist.Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor.Antithrombotic effects of synthetic peptides targeting various functional domains of thrombinSelective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons.Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents.Platelets and fibrinolysis.The use of antithrombotic therapies in reducing synthetic small-diameter vascular graft thrombosis.The arterial thrombotic process and emerging drugs for its control.Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties.Specific thrombin inhibitors in vivo.Novel antithrombotic therapy.New antithrombotic strategies for resistant thrombotic processes.Prevention of Restenosis by Local Drug Delivery.The anion-binding exosite is critical for the high affinity binding of thrombin to the human thrombin receptor.Structure-activity analysis of synthetic alpha-thrombin-receptor-activating peptides.Antithrombotic effect of a novel recombinant hirudin analogue, CX-397, in a rat arterial thrombosis model.Evidence for common structural changes in thrombin induced by active-site or exosite bindingAutocrine production of basic fibroblast growth factor translated from novel synthesized mRNA mediates thrombin-induced mitogenesis in smooth muscle cells.Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.Hepatic and extrahepatic factors critical for liver injury during lipopolysaccharide exposure.Macromolecular complex assembly of prothrombinase is a central process of thrombosis.The Membrane Glycoprotein IIb/IIIa Complex Mediates Deposition of Thrombin-stimulated Blood Platelets on Polystyrene Plastic Under Static Conditions.Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
P2860
Q24561385-F7365D2D-7A8D-4C66-A444-ACCBECD8E53CQ24627747-60DEC2A4-4AB5-4600-B99D-DDFEE75A6F1CQ33392630-A9C5A6D9-F6C3-4AF9-889F-7CECA81F957CQ33499192-48F10203-957E-424B-AEAB-15697AD0A28BQ33684119-9AC3565A-666F-4199-B881-177B17FF3244Q33905952-A533F41F-AE00-4B84-85EE-55C35BDA0DE6Q35597476-7FC7CACE-5C98-4239-90D9-354879C4984BQ35601268-52763C6A-D50C-4873-9CA2-6470D2BB1C29Q35607594-0CC5369B-983B-46AC-B4C4-AF4A08E0C96DQ35979576-E3714437-A23B-416B-A6E4-483338FDEDBDQ36530923-78FB3314-1865-4C73-B76B-75ACC9D0ABD2Q37090907-3E35C6B0-10BE-40F0-A221-E93E5A31552BQ37396961-F0494BCE-FCE3-4AA1-B0D2-D252F95696A2Q37711747-3590F995-AC9D-4F52-9874-39FA2DEFBE1EQ37806238-5D05DF72-6F51-40E8-A521-69F8038EA765Q37981652-C6E56BF9-9F3C-4627-BCF1-F2CA9F9C4DBAQ40486473-3FAE68A3-A86B-4F25-9538-2F968993F21BQ40511637-5F148EC0-71C7-43CB-9CB0-A9B9146557AEQ40664734-D90B7D8C-5DC9-485A-9AB6-A476DAD5575EQ40725160-C5B56558-7368-4822-8CEE-57B0183D1285Q40727618-FA344EE5-69A0-4D84-8791-F98055B4DE0FQ40942901-7C742FF0-61E0-46F6-B54D-BB94F44E95FCQ41504207-DBFF09C1-73B2-4685-B4CE-2728DA1CB89FQ41547675-B40C1DB1-49CA-4710-9559-E9DE5038FE57Q41834459-3E8BFCD1-C600-4810-88B3-6D30DBCC1F3CQ41971795-0783C2E3-B3C3-4E26-B92D-2DA0C7658315Q42163574-73EB8972-FA69-48E4-8E4D-0DE7594747EDQ42370934-57FF5D89-A7A3-4BEB-B528-BEA291623282Q43797527-C053A3C3-DD96-4102-95C8-FFCE9D493ABAQ46403959-9F1AB1FF-B3F2-4EC8-A71C-4AB4884AB372Q47776991-BE6662EB-0E61-42DE-8BA6-E361C40D9B4FQ48089546-A79C0B09-12BA-4919-BD9B-8ABB19C20CB4Q53794693-07699FD3-8992-4C04-85B1-3BBAF43A2241
P2860
Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Interruption of acute platelet ...... -L-arginyl chloromethyl ketone
@ast
Interruption of acute platelet ...... -L-arginyl chloromethyl ketone
@en
Interruption of acute platelet ...... L-arginyl chloromethyl ketone.
@nl
type
label
Interruption of acute platelet ...... -L-arginyl chloromethyl ketone
@ast
Interruption of acute platelet ...... -L-arginyl chloromethyl ketone
@en
Interruption of acute platelet ...... L-arginyl chloromethyl ketone.
@nl
prefLabel
Interruption of acute platelet ...... -L-arginyl chloromethyl ketone
@ast
Interruption of acute platelet ...... -L-arginyl chloromethyl ketone
@en
Interruption of acute platelet ...... L-arginyl chloromethyl ketone.
@nl
P2860
P356
P1476
Interruption of acute platelet ...... -L-arginyl chloromethyl ketone
@en
P2093
L A Harker
S R Hanson
P2860
P304
P356
10.1073/PNAS.85.9.3184
P407
P577
1988-05-01T00:00:00Z